共 40 条
- [21] High Expression of Myocyte Enhancer Factor 2C (MEF2C) Is Associated with Adverse Risk Features and Poor Outcome in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology GroupBLOOD, 2015, 126 (23)Laszlo, George S.Alonzo, Todd A.Gudgeon, Chelsea J.Harrington, Kimberly H.Kentsis, AlexGerbing, Robert B.Wang, Yi-ChengRies, Rhonda E.Raimondi, Susana C.Hirsch, Betsy A.Gamis, Alan S.Meshinchi, SoheilWalter, Roland B.
- [22] High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology GroupJournal of Hematology & Oncology, 8George S. LaszloTodd A. AlonzoChelsea J. GudgeonKimberly H. HarringtonAlex KentsisRobert B. GerbingYi-Cheng WangRhonda E. RiesSusana C. RaimondiBetsy A. HirschAlan S. GamisSoheil MeshinchiRoland B. Walter
- [23] High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupJOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8Laszlo, George S.Alonzo, Todd A.Gudgeon, Chelsea J.Harrington, Kimberly H.Kentsis, AlexGerbing, Robert B.Wang, Yi-ChengRies, Rhonda E.Raimondi, Susana C.Hirsch, Betsy A.Gamis, Alan S.Meshinchi, SoheilWalter, Roland B.
- [24] The Transcription Factor Neural Retina Leucine Zipper (NRL) Controls Photoreceptor-specific Expression of Myocyte Enhancer Factor Mef2c from an Alternative PromoterJOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (40) : 34893 - 34902Hao, HongTummala, PadmajaGuzman, EduardoMali, Raghuveer S.Gregorski, JaninaSwaroop, AnandMitton, Kenneth P.
- [25] Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology GroupJournal of Hematology & Oncology, 9George S. LaszloTodd A. AlonzoChelsea J. GudgeonKimberly H. HarringtonAlex KentsisRobert B. GerbingYi-Cheng WangRhonda E. RiesSusana C. RaimondiBetsy A. HirschAlan S. GamisSoheil MeshinchiRoland B. Walter
- [26] Myocyte-specific enhancer factor 2c triggers transdifferentiation of adipose tissue-derived stromal cells into spontaneously beating cardiomyocyte-like cellsScientific Reports, 11Shinichiro TakashimaSoichiro UsuiOto InoueChiaki GotenKosei YamaguchiYusuke TakedaShihe CuiYoshio SakaiKenshi HayashiKenji SakataMasa-aki KawashiriMasayuki Takamura
- [27] Myocyte-specific enhancer factor 2c triggers transdifferentiation of adipose tissue-derived stromal cells into spontaneously beating cardiomyocyte-like cellsSCIENTIFIC REPORTS, 2021, 11 (01)Takashima, ShinichiroUsui, SoichiroInoue, OtoGoten, ChiakiYamaguchi, KoseiTakeda, YusukeCui, ShiheSakai, YoshioHayashi, KenshiSakata, KenjiKawashiri, Masa-akiTakamura, Masayuki
- [28] Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophySCIENTIFIC REPORTS, 2016, 6Tang, Chun-MeiLiu, Fang-zhouZhu, Jie-NingFu, Yong-HengLin, Qiu-XiongDeng, Chun-YuHu, Zhi-QinYang, HuiZheng, Xi-LongCheng, Jian-DingWu, Shu-LinShan, Zhi-Xin
- [29] Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophyScientific Reports, 6Chun-Mei TangFang-zhou LiuJie-Ning ZhuYong-Heng FuQiu-Xiong LinChun-Yu DengZhi-Qin HuHui YangXi-Long ZhengJian-Ding ChengShu-Lin WuZhi-Xin Shan
- [30] High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group (vol 8, 115, 2015)Journal of Hematology & Oncology, 2016, 9Laszlo, George S.Alonzo, Todd A.Gudgeon, Chelsea J.Harrington, Kimberly H.Kentsis, AlexGerbing, Robert B.Wang, Yi-ChengRies, Rhonda E.Raimondi, Susana C.Hirsch, Betsy A.Gamis, Alan S.Meshinchi, SoheilWalter, Roland B.